Jim Simons Keros Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$31.57 - $43.02 $779,779 - $1.06 Million	-24,700 Reduced 36.11%	43,700 $1.39 Million
Q2 2023 Aug 11, 2023	SELL	$37.26 - $51.01 $1.96 Million - $2.69 Million	-52,700 Reduced 43.52%	68,400 $2.75 Million
Q1 2023 May 12, 2023	BUY	$41.44 - $59.32 $1.21 Million - $1.73 Million	29,200 Added 31.77%	121,100 $5.17 Million
Q4 2022 Feb 13, 2023	SELL	$39.45 - $51.77 $209,085 - $274,381	-5,300 Reduced 5.45%	91,900 $4.41 Million
Q3 2022 Nov 14, 2022	SELL	$27.8 - $40.12 $1.24 Million - $1.79 Million	-44,500 Reduced 31.4%	97,200 $3.66 Million

Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $3.55 Million - $9.14 Million	136,400 Added 2573.58%	141,700 $3.92 Million
Q1 2022 May 13, 2022	BUY	$42.12 - $59.36 $223,236 - $314,608	5,300 New	5,300 $288,000
Q4 2021 Feb 11, 2022	SELL	$36.95 - $62.89 $907,935 - $1.55 Million	-24,572 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.27 - $43.71 $719,222 - $1.07 Million	24,572 New	24,572 $972,000
Q1 2021 May 13, 2021	SELL	$54.0 - $75.28 $545,400 - $760,328	-10,100 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$36.0 - $82.74 $273,600 - $628,824	-7,600 Reduced 42.94%	10,100 $712,000
Q3 2020 Nov 13, 2020	BUY	$27.04 - $62.21 $308,256 - $709,194	11,400 Added 180.95%	17,700 $683,000
Q2 2020 Aug 13, 2020	BUY	$20.08 - $40.39 $126,503 - $254,457	6,300 New	6,300 $236,000

153

26.7M

47.6K

34.5K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.